Your browser doesn't support javascript.
loading
Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study.
Jacquet, J-M; Donnadieu-Rigole, H; Peries, M; Makinson, A; Nagot, N; Reynes, J; Peyriere, H.
Afiliación
  • Jacquet JM; Department of Infectious Diseases, Montpellier University Hospital, Montpellier, France.
  • Donnadieu-Rigole H; Department of Addictology, Nimes University Hospital, Nimes, France.
  • Peries M; Department of Addictology, Montpellier University Hospital, Montpellier, France.
  • Makinson A; Pathogenesis and Control of Chronic Infections, Montpellier University, INSERM UMR1058, CHU Montpellier, Montpellier, France.
  • Nagot N; Department of Infectious Diseases, Montpellier University Hospital, Montpellier, France.
  • Reynes J; INSERM U1175/IRD UMI 233, Montpellier University, Montpellier, France.
  • Peyriere H; Pathogenesis and Control of Chronic Infections, Montpellier University, INSERM UMR1058, CHU Montpellier, Montpellier, France.
HIV Med ; 20(4): 286-290, 2019 04.
Article en En | MEDLINE | ID: mdl-30706622
ABSTRACT

OBJECTIVES:

Screening, brief intervention and referral to treatment (SBIRT) is an evidence-based practice used to identify, reduce and prevent problematic use and abuse of, and dependence on, tobacco, alcohol and psychoactive substances. To date, the pertinence of this practice among people living with HIV (PLHIV) is unknown. In this pilot study, we aimed to assess the acceptability of SBIRT in a cohort of HIV-infected out-patients who were asked about their consumption of alcohol, tobacco and psychoactive substances.

METHODS:

A monocentric study was performed at the University Hospital of Montpellier. In a 6-month period, 20 trained physicians screened for the consumption of alcohol [using the Alcohol Use Disorders Identification Test (AUDIT)], tobacco (using the Short Fagerstrom Test) and psychoactive substances [using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) V3.0] via an auto-questionnaire and proposed a brief intervention to patients with misusage.

RESULTS:

One thousand and eighteen PLHIV completed the questionnaire, and 861 [84.6%; 95% confidence interval (CI) 82.2-86.7%] PLHIV returned it to the physician. Among the latter, 650 patients wished to discuss the answers with their physician (75.5%; 95% CI 72.5-78.3%), and brief interventions were realized in 405 patients (62.3%).

CONCLUSIONS:

SBIRT is a simple screening and harm reduction tool that is well accepted by PLHIV in out-patient clinics. This method could be implemented in routine HIV care to screen and manage patients systematically for harmful substance use.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prevención Primaria / Aceptación de la Atención de Salud / Infecciones por VIH / Tamizaje Masivo / Trastornos Relacionados con Sustancias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prevención Primaria / Aceptación de la Atención de Salud / Infecciones por VIH / Tamizaje Masivo / Trastornos Relacionados con Sustancias Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: HIV Med Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2019 Tipo del documento: Article País de afiliación: Francia